FUROSEMIDE , DULOXETINE
EORTC 2237-BCG-QLG
Phase 3 small_molecule active
Quick answer
FUROSEMIDE , DULOXETINE for ER positive HER2 negative breast cancer stages I-II is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- ER positive HER2 negative breast cancer stages I-II
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active